MedPath

Japanese Longitudinal Biomarker Study in PSP and CBD

Not Applicable
Recruiting
Conditions
progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), corticobasal syndrome (CBS)
Registration Number
JPRN-UMIN000018468
Lead Sponsor
iigata University, Brain Research Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

fulfill the diagnostic criteria of other neurodegenerative disorders

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
- Elucidation of the natural history - Development of new biomarker(s)
Secondary Outcome Measures
NameTimeMethod
- Clinical evaluations including cognitive, language, oculomotor, and motor functions during the observation period. - Clinical severity - MRI (volumetric analysis) - Known CSF and blood biomarkers - Neuropathological examination
© Copyright 2025. All Rights Reserved by MedPath